 1.png)
How do I contact Amneal or Impax?
Amneal, Impax and/or Gemini Laboratories Products: Report adverse events, product quality complaints and for medical information inquiries in the United States. Call: (877) 835-5472, option 1 or email: [email protected]
What is the Patient Assistance Program?
Our patient assistance program is just one of the many ways we help patients in need. Since 2012, our patient assistance program has provided free medicines to thousands of eligible patients.
What is the Amneal Patient Assistance Program?
The Amneal Patient Assistance Program offers eligible individuals the opportunity to apply to receive free medication for up to one year of: RYTARY® (carbidopa and levodopa) and EMVERM® (mebendazole) chewable tablets.
Summary
Thank you for checking into Impax Laboratories, Inc patient assistance program. As of January 24th, 2012 we do not have any specific information related to Impax Laboratories, Inc's program. Please check back regularly as we are updating our database of information daily.
Eligibility
Most programs have income, age, and other eligibility requirements. At this current time we don´t have the eligibility information for Impax Laboratories, Inc's program.
Other Tips
If you have any questions please call the Impax Laboratories, Inc program directly.
Sudden Price Spikes in Off-Patent Prescription..
Dec 9, 2016 — The drug could get dropped from an insurance plan formulary; an...
Accredited Business
Guarantees that a business meets BBB accreditation standards in the US and Canada.
TopTen Reviews
Highest customer reviews on one of the most highly-trusted product review platforms.
How does Impax help Europe?from impax.eu
IMPAX will contribute to Europe’s pharmaceutical industry by adopting “Industry 4.0” digitalization and automation principles and will facilitate the European market shift towards CM and PAT systems, boosting the uptake of more competitive manufacturing technologies.
What is Impax Laboratories?from forbes.com
is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals. In the generic pharmaceuticals market, the Company focuses on controlled-release generic versions of brand-name pharmaceuticals, covering a range of therapeutic areas. In the brand-name pharmaceuticals market, the Company is developing products for the treatment of central nervous system (CNS) disorders. The Company's brand-name
What is the product portfolio of Impax?from forbes.com
product portfolio consists of development-stage projects to which the Company applies its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. It operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceuticals Division (Impax Division).
How much does epinephrine cost?from drugs.com
The cost for epinephrine injectable kit 0.3 mg is around $272 for a supply of 2 kits, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
How much does a free drug card save?from drugs.com
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
What is epinephrine used for?from drugs.com
Epinephrine is a member of the adrenergic bronchodilators drug class and is commonly used for Adams-Stokes Syndrome, Allergic Reactions, Anaphylaxis, and others.
What is myAbbVie Assist?from abbvie.com
myAbbVie Assist. We believe that people who need our medicines should be able to get them. That’s why myAbbVie Assist provides free AbbVie medicine to qualifying patients . If you have any questions, visit the FAQs or call us at 1-800-222-6885. AbbVie is committed to helping patients get the medicines they need.
How to contact Abbvie?from abbvie.com
If you have any questions, visit the FAQs or call us at 1-800-222-6885. AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients.
How to contact Xifaxan?from xifaxan.com
Patients who need assistance with their monthly copays can call 1-866-XIFAXAN ( 1-866-943-2926 ).
What is Xifaxan 550 mg?from xifaxan.com
XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.
What is Salix Pharmaceuticals?from patientassistance.com
Salix Pharmaceuticals is a company focused on gastrointestinal diseases . Salix has a special search and development team, dedicated to the discovery of drugs which are already in the late stages of development, or are otherwise currently in the marketplace. Salix ensures that their products have acquired great responses in their studies for safety and efficacy. Working hard to maximize the commercialization of their products, Salix outsources the manufacturing of their products to result in cost effective drugs for their clientèle.
Does Xifaxan 1 cover commercial insurance?from xifaxan.com
of commercially insured patients have coverage for XIFAXAN 1†§
Is Xifaxan covered by Medicare?from xifaxan.com
Double-check coverage; Medicare excludes certain kinds of drugs, but XIFAXAN is not in those categories. Medication not covered. You can ask insurance plan to reevaluate; XIFAXAN is covered for 99% of commercially insured patients and 95% of Medicare patients 1†§. † Salix Pharmaceuticals does not guarantee coverage or reimbursement for the product.
How many Americans can't afford medication?from patientassistance.com
There are over 100 million Americans that either can‚t afford their medication or are struggling to afford their medication. We aim to help each and every American in that situation.
Can Xifaxan cause diarrhea?from xifaxan.com
Clostridium difficile -associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including XIFAXAN, and may range in severity from mild diarrhea to fatal colitis. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued.
